Italy: market value of biopharmaceuticals 2017, by type
This statistic depicts the market value of biopharmaceuticals becoming off-patent between 2017 and 2022 in Italy as of 2017, by type. According to data, Adalimumab and Trastuzumab generated the greatest market values over the year considered, with 270 and 266 million euros, respectively.